Community observations, not medical advice.Always speak with a qualified healthcare professional.
supplement × Neurological

CBD Oil for Spasticity (MS)

Non-intoxicating cannabinoid that modulates the endocannabinoid system indirectly and acts on serotonin 5-HT1A receptors; studied for anxiety, inflammatory pain, and sleep disruption.

-published research: study records
-published research: findings
Not formally gradedcertainty of the research
On this pageOverviewEvidenceCommunity outcomesRelated
Why CBD Oil for Spasticity (MS)?

The connection

Muscle stiffness and spasms, commonly in multiple sclerosis. NHS-prescribed cannabis-based medicines are licensed for MS spasticity.

Also known as: Cannabidiol, CBD

Published research

CBD Oil × Spasticity (MS): at a glance

Every published result for this pair, extracted and audited.

Published research

CBD Oil / Spasticity (MS): publication years

What this means: Counts describe research quantity, not treatment effectiveness or certainty.

CBD Oil / Spasticity (MS): publication years (publications, count)
CategoryPublications (count)
20232
20242
20262
← Zoom out: all evidence for CBD OilZoom out: compare compounds for Spasticity (MS) →
Published research

CBD Oil × Spasticity (MS): the evidence base

Hand-selected PubMed studies, linked to the originals.

6studies referenced
6journals
2023–2026publication range

Ordered by strength of evidence, then result direction.

01Integrative Systematic Review on Pharmacological, Psychotherapeutic, and Neurostimulatory Treatment Options in Treatment-Resistant Anxiety DisordersSchiele MA, et al. · Psychotherapy and psychosomatics · 2026PMID 40946318 ↗02The effects of oral cannabidiol supplementation on blood pressure in adults: a systematic review of randomised controlled trialsRoberts A, et al. · Journal of cannabis research · 2026PMID 42321899 ↗03Effectiveness of Cannabidiol to Manage Chronic Pain: A Systematic ReviewMohammed SYM, et al. · Pain management nursing : official journal of the American Society of Pain Management Nurses · 2024PMID 37953193 ↗04Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysisHan K, et al. · Psychiatry research · 2024PMID 38924898 ↗05Interventions for generalized anxiety disorderByrne GJ · Current opinion in psychiatry · 2023PMID 36705012 ↗06Cannabis-based medicines and medical cannabis for adults with cancer painHäuser W, et al. · The Cochrane database of systematic reviews · 2023PMID 37283486 ↗
Search PubMed ↗View on PubChem ↗Find clinical trials ↗

Community experiences

Contributors volunteered; this does not establish treatment effectiveness or population incidence.

Reported changes

No publishable community breakdown is available. This does not establish that no reports exist.

Share your experience
Important: This page reflects observational, aggregate-only community reporting and independent published research. It is not medical advice, and it does not claim any compound treats, cures, or is effective for any condition. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or treatment.